Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-07
2010-12-14
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S251000
Reexamination Certificate
active
07851478
ABSTRACT:
For example, an agent for preventing and/or treating movement disorder comprising, as an active ingredient, a triazolopyrimidine derivative having an adenosine A2Areceptor antagonistic action, which is represented by the following formula (I):(wherein R1represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group, R2represents a hydrogen atom, or the like, R3represents —WR4, or the like, and Q1represents a hydrogen atom or 3,4-dimethoxybenzyl), or a pharmaceutically acceptable salt thereof, and the like are provided.
REFERENCES:
patent: 6066642 (2000-05-01), Jacobson et al.
patent: 6222035 (2001-04-01), Tsumuki et al.
patent: 6545000 (2003-04-01), Shimada et al.
patent: 7465740 (2008-12-01), Neustadt et al.
patent: 2002/0099061 (2002-07-01), Neustadt et al.
patent: 2003/0171381 (2003-09-01), Tulshian et al.
patent: 2003/0191130 (2003-10-01), Neustadt et al.
patent: 2003/0212059 (2003-11-01), Boyle et al.
patent: 2004/0097526 (2004-05-01), Gillespie et al.
patent: 2004/0138235 (2004-07-01), Grzelak et al.
patent: 2004/0152659 (2004-08-01), Matsuoka et al.
patent: 2004/0198753 (2004-10-01), Kase et al.
patent: 2005/0014815 (2005-01-01), Sundermann et al.
patent: 2005/0090492 (2005-04-01), Kuo et al.
patent: 2000-516910 (2000-12-01), None
patent: 2001-302648 (2001-10-01), None
patent: 2003-535094 (2003-11-01), None
patent: 2004-517862 (2004-06-01), None
patent: 2005-506352 (2005-03-01), None
patent: 2005-511697 (2005-04-01), None
patent: WO 98/42711 (1998-10-01), None
patent: WO 99/43678 (1999-09-01), None
patent: WO 00/17201 (2000-03-01), None
patent: WO 00/69464 (2000-11-01), None
patent: WO 03/032996 (2003-04-01), None
patent: WO 03/048156 (2003-06-01), None
patent: WO 03/063876 (2003-08-01), None
patent: WO 2004/092173 (2004-10-01), None
patent: WO 2004/094431 (2004-11-01), None
patent: WO 2005/044819 (2005-05-01), None
patent: WO 2005/054245 (2005-06-01), None
Kim, et al., J. Med. Chem., 39: 4142-4148, 4143 (1996).
Kim et al.,J. Med. Chem., 39: 4142-4148 (1996).
Brown et al.,IDrugs, 5(5): 454-468 (Jan. 1, 2002).
Simola et al.,Experimental Neurology, 189(1): 182-188 (Sep. 1, 2004).
Kadowaki Takako
Kobayashi Minoru
Seno Naoki
Shiozaki Shizuo
Kyowa Hakko Kirin Co., Ltd.
Leeser Erich A
Leydig , Voit & Mayer, Ltd.
Wilson James O
LandOfFree
Agent for preventing and/or treating movement disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for preventing and/or treating movement disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for preventing and/or treating movement disorder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4180976